2,8-bis(trifluoromethyl)quinoline analogs show improved anti-Zika virus activity, compared to mefloquine.
暂无分享,去创建一个
P. Bozza | G. Barbosa-Lima | T. Souza | M. D. de Souza | Y. R. Vieira | A. M. Moraes | E. da Silva | Andressa Marttorelli | Caroline S de Freitas | J. C. Neto | A. D. S. Araújo | Caroline S. de Freitas | T. M. Souza
[1] B. Shaz,et al. Zika Virus and the Blood Supply: What Do We Know? , 2017, Transfusion medicine reviews.
[2] L. Rodrigues,et al. Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study. , 2016, The Lancet. Infectious diseases.
[3] X. de Lamballerie,et al. Long-Lasting Persistence of Zika Virus in Semen. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] Q. S. Huang,et al. Sexual Transmission of Zika Virus and Persistence in Semen, New Zealand, 2016 , 2016, Emerging infectious diseases.
[5] Ruili Huang,et al. Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen , 2016, Nature Medicine.
[6] Maria Teresa Dell'Anno,et al. Zika Virus Disrupts Phospho-TBK1 Localization and Mitosis in Human Neuroepithelial Stem Cells and Radial Glia. , 2016, Cell reports.
[7] J. Sejvar,et al. Guillain-Barré Syndrome During Ongoing Zika Virus Transmission - Puerto Rico, January 1-July 31, 2016. , 2016, MMWR. Morbidity and mortality weekly report.
[8] R. Lanciotti,et al. Pathology of congenital Zika syndrome in Brazil: a case series , 2016, The Lancet.
[9] Nikos Vasilakis,et al. A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection. , 2016, Cell host & microbe.
[10] Carolina Q. Sacramento,et al. The clinically approved antiviral drug sofosbuvir impairs brazilian zika virus replication , 2016, bioRxiv.
[11] M. Diamond,et al. Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise , 2016, Cell.
[12] M. Busch,et al. Zika virus: a new challenge for blood transfusion , 2016, The Lancet.
[13] M. Diamond,et al. A Mouse Model of Zika Virus Pathogenesis. , 2016, Cell host & microbe.
[14] P. Garcez,et al. Chloroquine inhibits Zika Virus infection in different cellular models , 2016, bioRxiv.
[15] F. Kashanchi,et al. Zika Virus: A New Animal Model for an Arbovirus , 2016, PLoS neglected tropical diseases.
[16] J. Neyts,et al. The Viral Polymerase Inhibitor 7-Deaza-2’-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model , 2016, bioRxiv.
[17] J. Brooks,et al. Male-to-Male Sexual Transmission of Zika Virus--Texas, January 2016. , 2016, MMWR. Morbidity and mortality weekly report.
[18] Eric D'Ortenzio,et al. Evidence of Sexual Transmission of Zika Virus. , 2016, The New England journal of medicine.
[19] S. Rasmussen,et al. Zika Virus and Birth Defects--Reviewing the Evidence for Causality. , 2016, The New England journal of medicine.
[20] A. Act,et al. Zika Virus Infection in Pregnant Women in Rio de Janeiro - Preliminary Report. , 2016 .
[21] Graham Hall,et al. A Susceptible Mouse Model for Zika Virus Infection , 2016, bioRxiv.
[22] Sen Chen,et al. Mefloquine effectively targets gastric cancer cells through phosphatase-dependent inhibition of PI3K/Akt/mTOR signaling pathway. , 2016, Biochemical and biophysical research communications.
[23] L. Schuler‐Faccini,et al. Possible Association Between Zika Virus Infection and Microcephaly - Brazil, 2015. , 2016, MMWR. Morbidity and mortality weekly report.
[24] E. Laurini,et al. Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives. , 2015, European journal of medicinal chemistry.
[25] S. Vesenbeckh,et al. Mefloquine as a potential drug against multidrug-resistant tuberculosis , 2015, European Respiratory Journal.
[26] B. Lämmle,et al. Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine , 2015, Journal of NeuroVirology.
[27] D. Musso,et al. Potential Sexual Transmission of Zika Virus , 2015, Emerging infectious diseases.
[28] L. Bermudez,et al. Mefloquine and Its Enantiomers Are Active against Mycobacterium tuberculosis In Vitro and in Macrophages , 2014, Tuberculosis research and treatment.
[29] Peter J. Smith,et al. Synthesis of novel triazole-linked mefloquine derivatives: biological evaluation against Plasmodium falciparum. , 2014, Bioorganic & medicinal chemistry letters.
[30] K. Chu,et al. Mefloquine improved progressive multifocal leukoencephalopathy in a patient with immunoglobulin A nephropathy , 2014, Journal of Clinical Neuroscience.
[31] Yogesh Kumar,et al. Progressive Multifocal Leukoencephalopathy in a 62-Year-Old Immunocompetent Woman , 2014, Case reports in neurological medicine.
[32] B. Cavalcanti,et al. Mefloquine–Oxazolidine Derivatives: A New Class of Anticancer Agents , 2014, Chemical biology & drug design.
[33] S. Chuang,et al. Mefloquine induces cell death in prostate cancer cells and provides a potential novel treatment strategy in vivo , 2013, Oncology letters.
[34] T. Yamawaki,et al. Akinetic mutism caused by HIV-associated progressive multifocal leukoencephalopathy was successfully treated with mefloquine: a serial multimodal MRI Study. , 2012, Internal medicine.
[35] C. Kaiser,et al. Mefloquine-oxazolidine derivatives, derived from mefloquine and arenecarbaldehydes: In vitro activity including against the multidrug-resistant tuberculosis strain T113. , 2012, Bioorganic & medicinal chemistry.
[36] B. Poojary,et al. Synthesis and antimicrobial activity of 1,2,3-triazoles containing quinoline moiety , 2010, Archives of pharmacal research.
[37] A. V. Adhikari,et al. New quinoline derivatives: synthesis and investigation of antibacterial and antituberculosis properties. , 2010, European journal of medicinal chemistry.
[38] K. Simon,et al. Identification and Characterization of Mefloquine Efficacy against JC Virus In Vitro , 2009, Antimicrobial Agents and Chemotherapy.
[39] R. Lanciotti,et al. Genetic and Serologic Properties of Zika Virus Associated with an Epidemic, Yap State, Micronesia, 2007 , 2008, Emerging infectious diseases.
[40] A. Kozikowski,et al. Design, Synthesis, and SAR Studies of Mefloquine‐Based Ligands as Potential Antituberculosis Agents , 2006, ChemMedChem.
[41] N. White,et al. Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. , 2004, Acta tropica.
[42] J. Wachira,et al. Cytotoxicity of novel trifluoromethylquinoline derivatives on human leukemia cells. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[43] D. Scudiero,et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. , 1988, Cancer research.
[44] G. Dick,et al. Zika virus. I. Isolations and serological specificity. , 1952, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[45] L. Reed,et al. A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .